TRDA
Entrada Therapeutics, Inc. · Healthcare
President and COO Nathan J Dowden sold $35K of Entrada Therapeutics, Inc.
Sold$34,753
$15.09Price
2,303Shares
−2%Stake
What TRDA did after the filing
- The stock from Wed, Sep 11 open, $14.72
- +15.3%
- S&P 500, same days
- +5.7%
Measured over 30 trading days, to the Oct 23 close.
Traded Fri, Sep 6. Filed Tue, Sep 10, 4:33 PM ET, after the close. Returns use the Sep 11 open and the Oct 23 close. Not investment advice.